Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G4BF
|
|||
| Former ID |
DIB002805
|
|||
| Drug Name |
DTaP-HepB prophylactic vaccine
|
|||
| Synonyms |
DTaP-HepB prophylactic vaccine (diphtheria/tetanus/pertussis/HBV)
Click to Show/Hide
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 3 | [1], [2] | |
| Company |
LG Life Sciences Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of LG Life Sciences Ltd. | |||
| REF 2 | ClinicalTrials.gov (NCT01896739) A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.